TY - JOUR
T1 - Personal protective equipment and intensive care unit healthcare worker safety in the COVID-19 era (PPE-SAFE): An international survey
AU - Tabah, Alexis
AU - Ramanan, Mahesh
AU - Laupland, Kevin B.
AU - Buetti, Niccolò
AU - Cortegiani, Andrea
AU - Mellinghoff, Johannes
AU - Conway Morris, Andrew
AU - Comporota, Luigi
AU - Zappella, Nathalie
AU - Elhadi, Muhammed
AU - Povoa, Pedro
AU - Amrein, Karin
AU - Vidal, Gabriela
AU - Derde, Lennie
AU - Bassetti, Matteo
AU - Francois, Guy
AU - Ssi yan kai, Nathalie
AU - De Waele, Jan J.
N1 - Funding Information:
Andrew Conway Morris is supported by a Clinical Research Career Development Fellowship from the Wellcome Trust (WT 2055214/Z/16/Z). Niccolò Buetti is currently receiving a Post.doc Mobility grant from the Swiss National Science Foundation (grant number: P400PM_183865) and a grant from the Bangerter-Rhyner Foundation.
Funding Information:
Dr. Tabah has nothing to disclose, Dr. Ramanan has nothing to disclose, Prof. Laupland has nothing to disclose, Dr. Buetti has nothing to disclose, Dr. Cortegiani has nothing to disclose, Mr. Mellinghoff has nothing to disclose, Dr. Conway Morris reports grants from Wellcome Trust, during the conduct of the study; Dr. Camporota has nothing to disclose, Dr. Zappella has nothing to disclose, Dr. Vidal has nothing to disclose, Dr. Elhadi has nothing to disclose, Dr. Povoa reports personal fess from Orion, personal fees from Pfizer and personal fees from Technofage, Dr. Amrein reports grants, personal fees and other from Fresenius Kabi, personal fees from Vifor Pharma, personal fees from Shire now part of Takeda, outside the submitted work, Dr. Derde reports grants from European Union, grants from ZonMw, outside the submitted work, Guy Francoishas nothing to disclose, Dr. Bassetti reports grants and personal fees from Pfizer, grants and personal fees from MSD, grants and personal fees from Menarini, grants and personal fees from Angelini, personal fees from Astellas, personal fees from Nabriva, grants and personal fees from Paratek, personal fees from Gilead, personal fees from Basilea, personal fees from Cidara, personal fees from Molteni, outside the submitted work; Dr. Ssi Yan Kai has nothing to disclose, Dr. De Waelereports grants from Research Foundation Flanders, during the conduct of the study; other from Bayer, other from Pfizer, other from MSD, other from Grifols, other from Accelerate, outside the submitted work;.
Funding Information:
This study was endorsed by, and communications were sent to the members of: ? European Society of Intensive Care Medicine (ESICM) ? European Society of Clinical Microbiology and Infectious Diseases Study Group for Infections in Critically Ill Patients ? ESCMID ESGCIP ? Societ? Italiana di Anestesia Analgesia Rianimazione e Terapia Intensiva (SIAARTI) ? Associazione Nazionale Infermieri di Area Critica (ANIARTI). ? Societ? Italiana di Terapaia Antinfettiva (SITA), Without mention of endorsement communications were sent to the members of: ? Soci?t? Fran?aise d'Anesth?sie et de R?animation (SFAR) ? The Australian and New Zealand Intensive Care Society (ANZICS) ? College Of Intensive Care Medicine of Australia and New Zealand (CICM ANZ) ? Sociedad Argentina de Terapia Intensiva (SATI) ? The Eurobact II study group. ? The DIANA study group ? Society for Healthcare Epidemiology of America (SHEA) ? Sociedade Portuguesa de Cuidados Intensivos (SPCI) ? Departments and networks of the PPE-SAFE contributors
Publisher Copyright:
© 2020
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/10
Y1 - 2020/10
N2 - Purpose: To survey healthcare workers (HCW) on availability and use of personal protective equipment (PPE) caring for COVID-19 patients in the intensive care unit (ICU). Materials and method: A web-based survey distributed worldwide in April 2020. Results: We received 2711 responses from 1797 (67%) physicians, 744 (27%) nurses, and 170 (6%) Allied HCW. For routine care, most (1557, 58%) reportedly used FFP2/N95 masks, waterproof long sleeve gowns (1623; 67%), and face shields/visors (1574; 62%). Powered Air-Purifying Respirators were used routinely and for intubation only by 184 (7%) and 254 (13%) respondents, respectively. Surgical masks were used for routine care by 289 (15%) and 47 (2%) for intubations. At least one piece of standard PPE was unavailable for 1402 (52%), and 817 (30%) reported reusing single-use PPE. PPE was worn for a median of 4 h (IQR 2, 5). Adverse effects of PPE were associated with longer shift durations and included heat (1266, 51%), thirst (1174, 47%), pressure areas (1088, 44%), headaches (696, 28%), Inability to use the bathroom (661, 27%) and extreme exhaustion (492, 20%). Conclusions: HCWs reported widespread shortages, frequent reuse of, and adverse effects related to PPE. Urgent action by healthcare administrators, policymakers, governments and industry is warranted.
AB - Purpose: To survey healthcare workers (HCW) on availability and use of personal protective equipment (PPE) caring for COVID-19 patients in the intensive care unit (ICU). Materials and method: A web-based survey distributed worldwide in April 2020. Results: We received 2711 responses from 1797 (67%) physicians, 744 (27%) nurses, and 170 (6%) Allied HCW. For routine care, most (1557, 58%) reportedly used FFP2/N95 masks, waterproof long sleeve gowns (1623; 67%), and face shields/visors (1574; 62%). Powered Air-Purifying Respirators were used routinely and for intubation only by 184 (7%) and 254 (13%) respondents, respectively. Surgical masks were used for routine care by 289 (15%) and 47 (2%) for intubations. At least one piece of standard PPE was unavailable for 1402 (52%), and 817 (30%) reported reusing single-use PPE. PPE was worn for a median of 4 h (IQR 2, 5). Adverse effects of PPE were associated with longer shift durations and included heat (1266, 51%), thirst (1174, 47%), pressure areas (1088, 44%), headaches (696, 28%), Inability to use the bathroom (661, 27%) and extreme exhaustion (492, 20%). Conclusions: HCWs reported widespread shortages, frequent reuse of, and adverse effects related to PPE. Urgent action by healthcare administrators, policymakers, governments and industry is warranted.
KW - COVID-19
KW - Health care workers
KW - Intensive care
KW - Personal protective equipment
KW - Safety
UR - http://www.scopus.com/inward/record.url?scp=85086596769&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85086596769&partnerID=8YFLogxK
U2 - 10.1016/j.jcrc.2020.06.005
DO - 10.1016/j.jcrc.2020.06.005
M3 - Article
C2 - 32570052
AN - SCOPUS:85086596769
VL - 59
SP - 70
EP - 75
JO - Journal of Critical Care
JF - Journal of Critical Care
SN - 0883-9441
ER -